What is hepatogastric (bile) reflux?

What is Hepatojugular Reflux (Bile Reflux)?

Bile reflux is the pathological retrograde flow of bile and other duodenal contents (including pancreatic enzymes and intestinal secretions) from the duodenum backward into the stomach, and potentially into the esophagus, causing inflammation, symptoms, and potential mucosal injury. 1, 2

Pathophysiology and Mechanism

• Bile reflux occurs when the normal protective mechanisms at the pylorus fail, allowing alkaline duodenal fluid to regurgitate into the stomach. 3, 4
• Primary bile reflux results from antroduodenal motility disorders that disrupt normal pyloric function, while secondary bile reflux arises after surgical procedures that destroy, remove, or bypass the pylorus (such as cholecystectomy, gastrectomy, or gastric bypass operations). 3, 4, 5
• The refluxed bile acids, pancreatic enzymes, and alkaline secretions can damage the gastric mucosa, leading to chronic atrophic gastritis and are an important factor in the pathogenesis of gastric ulcer. 3, 2
• When bile reflux occurs in conjunction with gastroesophageal reflux, the backwash of duodenal content into the esophagus creates mixed (alkaline and acid) reflux, which can cause severe esophageal mucosal damage including Barrett's metaplasia and adenocarcinoma. 4

Clinical Presentation

• Typical symptoms include epigastric pain (especially right below the ribs), nausea, bilious vomiting, bloating, burping, heartburn, and bile regurgitation. 3, 4, 5
• Post-cholecystectomy bile reflux gastritis occurs in approximately 61.8% of patients who have undergone cholecystectomy, compared to only 16.7% in control populations. 5
• In post-gastrectomy patients, bile reflux gastritis presents as a disabling condition characterized by abdominal pain, bilious vomiting, and weight loss. 6
• Hiccups have been reported as an unusual manifestation of excessive bile accumulation in the stomach causing gastric overdistension. 1

Risk Factors

• Diabetes, obesity, elevated gastric bilirubin levels, and elevated stomach pH are all significant risk factors for developing bile reflux gastritis. 5
• Surgical procedures including cholecystectomy, gastrectomy, and one-anastomosis gastric bypass (OAGB) dramatically increase the risk, with bile reflux documented in 53% of post-OAGB patients. 5, 7

Diagnostic Approach

• Endoscopic visualization can confirm the presence of bile in the stomach and document associated gastritis, though these findings support but are not specific for the diagnosis. 3, 6
• Hepatobiliary scintigraphy (HIDA scan) with a dedicated protocol is the least invasive test for diagnosing bile reflux, offering good sensitivity, patient tolerability, and reproducibility. 7
• 24-hour intraluminal bile monitoring represents a more sophisticated diagnostic method for quantifying bile exposure. 4
• Chemical analysis of gastric contents for bile markers (such as bilirubin) and measurement of gastric pH can support the diagnosis. 3, 5

Relationship to GERD

• Bile reflux is distinct from typical gastroesophageal reflux disease (GERD), which is defined by the American Gastroenterological Association as reflux of stomach contents causing troublesome symptoms and/or complications. 8
• While GERD primarily involves acid reflux and typically responds well to proton pump inhibitor therapy, bile reflux gastritis may respond to acid suppression but the response pattern differs and is often less predictable. 9
• Mixed reflux (both acid and bile) represents a more severe form of esophageal injury and is associated with increased risk of Barrett's esophagus and esophageal adenocarcinoma. 4

Treatment Considerations

• Medical therapy for bile reflux is difficult, non-specific, and relatively ineffective in controlling symptoms. 4, 6
• Proton pump inhibitors decrease the upstream effects of bile reflux on the esophagus by decreasing the volume of gastric secretions, but do not address the underlying bile reflux mechanism. 4
• Promotility agents (such as metoclopramide) may diminish gastric exposure to duodenal secretions by improving gastric emptying. 4
• Bile acid-binding agents (chelating agents) have shown disappointing results in clinical practice. 3, 6
• For severe, medically refractory bile reflux gastritis, surgical diversion of bile away from the gastric mucosa (such as Roux-en-Y diversion or duodenal switch procedure) is the treatment of choice, with pain relief achieved in approximately 85% of patients. 4, 6

Critical Clinical Pitfalls

• Do not confuse bile reflux gastritis with typical GERD—the pathophysiology, diagnostic approach, and treatment responses differ substantially. 9, 4
• Do not rely solely on endoscopic findings, as visualization of bile in the stomach can occur physiologically and does not confirm pathological bile reflux without correlation to symptoms and objective testing. 3, 6
• Do not expect robust symptom improvement with standard GERD therapies (PPIs alone), as bile reflux requires different management strategies. 4, 6
• Recognize that delayed gastric emptying is a common complication after Roux-en-Y diversion procedures, though surgical modifications can reduce this incidence. 6